PhD defence: Cathrine Fonnesbech Hjorth
The influence of genetics and socioeconomic position on breast cancer survivorship in premenopausal women
Info about event
The auditorium at the Department of Clinical Epidemiology, Aarhus University and on Zoom
On Thursday 30 June at 11.00, Cathrine Fonnesbech Hjorth defends her PhD dissertation entitled "Breast cancer survivorship after taxane-based chemotherapy. Studies in premenopausal women".
Women diagnosed with breast cancer before menopause are recommended a type of chemotherapy called taxanes. However, women with apparently identical clinical characteristics may vary considerably in their response to this treatment. Some experience a recurrence and/or die prematurely. Furthermore, it is different whether the women can continue their working lives, which may be challenged due to side effects of the treatment. Using a clinical database, researchers at Aarhus University identified 2600 women diagnosed with breast cancer and used data from Danish registries to demonstrate a social inequality in the women's prognosis over 10 years. In addition, the researchers collected biological samples from approx. 2300 of the women and linked their genetics to the same register data. They identified genetic markers that may be important for the individual woman's risk of recurrence and death. The researchers also examine the genes' impact on the womens subsequent working lives.
The summary is written by the PhD student.
The defence is public and takes place in the auditorium at the Department of Clinical Epidemiology, Aarhus University and on Zoom. Please read the attached press release for more information.